Stocks and Investing
Stocks and Investing
Tue, December 24, 2019
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Mon, December 23, 2019
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Fri, December 20, 2019
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Jeffrey Zekauskas Maintained (CC) at Hold with Decreased Target to $19 on, Dec 20th, 2019
Jeffrey Zekauskas of JP Morgan, Maintained "The Chemours Company" (CC) at Hold with Decreased Target from $21 to $19 on, Dec 20th, 2019.
Jeffrey has made no other calls on CC in the last 4 months.
There are 3 other peers that have a rating on CC. Out of the 3 peers that are also analyzing CC, 1 agrees with Jeffrey's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- PJ Juvekar of "Citigroup" Maintained at Hold with Increased Target to $21 on, Wednesday, November 6th, 2019
These are the ratings of the 2 analyists that currently disagree with Jeffrey
- John McNulty of "BMO Capital" Maintained at Buy with Increased Target to $25 on, Thursday, November 7th, 2019
- Don Carson of "Susquehanna" Upgraded from Hold to Buy and Decreased Target to $18 on, Tuesday, August 20th, 2019
Contributing Sources